Page last updated: 2024-08-23

nitazoxanide and rifamycins

nitazoxanide has been researched along with rifamycins in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	2 (33.33)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Bronze, MS; Greenfield, R; Greenfield, RA; Salvaggio, M; Sud, B	1
Finegold, SM; Molitoris, D; Väisänen, ML	1
Cabada, MM; Pantenburg, B; White, AC	1
Dang, MD; DuPont, HL; Garey, KW; Hasbun, R; Jiang, ZD; Koo, HL; Shah, D	1
Johnson, S; Soriano, MM	1
Abd-Elsalam, SM; Glal, KAM; Mostafa, TM	1

Reviews

4 review(s) available for nitazoxanide and rifamycins

Article	Year
Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide. The Journal of the Oklahoma State Medical Association, 2007, Volume: 100, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Drug Resistance, Microbial; Humans; Metronidazole; Nitro Compounds; Nitrofurantoin; Rifamycins; Rifaximin; Thiazoles; Tinidazole; Trimethoprim, Sulfamethoxazole Drug Combination	2007
Treatment of cryptosporidiosis. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:4 Topics: AIDS-Related Opportunistic Infections; Animals; Antiretroviral Therapy, Highly Active; Azithromycin; Biliary Tract Diseases; Coccidiostats; Cryptosporidiosis; Humans; Immunocompromised Host; Nitro Compounds; Paromomycin; Rifamycins; Rifaximin; Thiazoles	2009
Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert review of anti-infective therapy, 2010, Volume: 8, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fidaxomicin; Humans; Microbial Sensitivity Tests; Nitro Compounds; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Thiazoles; Treatment Outcome	2010
Treatment of Clostridium difficile infections. Infectious disease clinics of North America, 2015, Volume: 29, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin	2015

Trials

1 trial(s) available for nitazoxanide and rifamycins

Article	Year
Nitazoxanide versus rifaximin in preventing the recurrence of hepatic encephalopathy: A randomized double-blind controlled trial. Journal of hepato-biliary-pancreatic sciences, 2021, Volume: 28, Issue:10 Topics: Child; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Nitro Compounds; Prospective Studies; Quality of Life; Rifamycins; Rifaximin; Thiazoles	2021

Other Studies

1 other study(ies) available for nitazoxanide and rifamycins

Article	Year
Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Ampicillin; Bacteria, Anaerobic; Feces; Microbial Sensitivity Tests; Neomycin; Nitro Compounds; Rifamycins; Rifaximin; Sulbactam; Teicoplanin; Thiazoles; Vancomycin	2009

Article

Year

Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.

Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

Topics: Ampicillin; Bacteria, Anaerobic; Feces; Microbial Sensitivity Tests; Neomycin; Nitro Compounds; Rifamycins; Rifaximin; Sulbactam; Teicoplanin; Thiazoles; Vancomycin

2009